GLPBio

PI3K/Akt/mTOR Signaling

Research Areas

Products Related to PI3K/Akt/mTOR Signaling(719)

  • GC19202 structure
    GC19202IPI549
    CAS: 1693758-51-8
    Purity: >98.50%

    IPI549 (IPI549) is a potent and selective PI3Kγ inhibitor with an IC50 of 16 nM. IPI549 shows >100-fold selectivity over other lipid and protein kinases.

  • GC19227 structure
    GC19227LTURM34
    CAS: 1879887-96-3
    Purity: >99.00%

    LTURM34 is a specific DNA-PK inhibitor with an IC50 of 0.034 uM.

  • GC19256 structure
    GC19256MTX-211
    CAS: 1952236-05-3
    Purity: >98.00%

    MTX-211 is a dual inhibitor of EGFR and PI3K, used for the treatment of cancer and other diseases.

  • GC19269 structure
    GC19269O-304
    CAS: 1261289-04-6
    Purity: >99.50%

    O-304 is a small molecule AMPK activator.

  • GC19283 structure
    GC19283PF-04979064
    CAS: 1220699-06-8
    Purity: >99.50%

    PF-04979064 is a potent and selective PI3K/mTOR dual kinase inhibitor with Kis of 0.13 nM and 1.42 nM for PI3Kα and mTOR, respectively.

  • GC19286 structure
    GC19286PF-06409577
    CAS: 1467057-23-3
    Purity: >99.00%

    PF-06409577 is a potent and selective allosteric activator of AMPK α1β1γ1 isoform with an EC50 of 7 nM.

  • GC19300 structure
    GC19300PQR309
    CAS: 1225037-39-7
    Purity: >98.50%

    PQR309 is a potent, brain-penetrant, orally bioavailable, pan-class I PI3K/mTOR inhibitor with IC50s of 33nM, 451nM, 661nM, 708nM and 89nM for PI3Kα, PI3Kδ, PI3Kβ, PI3Kγ and mTOR, respectively.

  • GC19328 structure
    GC19328SF2523
    CAS: 1174428-47-7
    Purity: >98%

    SF2523 is a highly selective and potent inhibitor of PI3K with IC50s of 34 nM, 158 nM, 9 nM, 241 nM and 280 nM for PI3Kα, PI3Kγ, DNA-PK, BRD4 and mTOR, respectively.

  • GC19355 structure
    GC19355Umbralisib
    CAS: 1532533-67-7
    Purity: >98.50%

    TGR-1202 is a PI3Kδ inhibitor, with IC50 and EC50 of 22.2 nM and 24.3 nM, respectively.

  • GC19390 structure
    GC19390YU238259
    CAS: 1943733-16-1
    Purity: >99.50%

    YU238259 is an inhibitor of homology-dependent DNA repair (HDR), used for cancer research.

  • GC19411 structure
    GC19411IITZ-01
    CAS: 1807988-47-1
    Purity: >99.00%

    IITZ-01 is a potent lysosomotropic autophagy inhibitor with single-agent antitumor activity, with an IC50 of 2.62 μM for PI3Kγ.

  • GC19471 structure
    GC19471Leniolisib
    CAS: 1354690-24-6
    Purity: >99.00%

    A potent and selective PI3Kδ inhibitor

  • GC19484 structure
    GC19484BAY1125976
    CAS: 1402608-02-9
    Purity: >99.50%

    A selective allosteric Akt1/Akt2 inhibitor

  • GC19540 structure
    GC19540α-Linolenic Acid
    CAS: 463-40-1
    Purity: >99.50%

    An essential fatty acid found in leafy green vegetables

  • GC19843 structure
    GC19843Nimbolide
    CAS: 25990-37-8
    Purity: >98.00%

    Nimbolide is a triterpene derived from the leaves and flowers of Azadirachta indica L. Nimbolide inhibits NF- κ B induces tumor cell apoptosis. Nimbolide inhibited CDK4 / Cdk6 kinase activity. Nimbolide inhibits NF- κ B. Wnt, PI3K Akt, MAPK and JAK-STAT signaling pathways.

  • GC19921 structure
    GC19921Phenylarsine Oxide
    CAS: 637-03-6
    Purity: >98.00%
  • GC25018 structure
    GC250184-Vinylcyclohexene dioxide
    CAS: 106-87-6
    Purity: >96.00%

    4-Vinylcyclohexene dioxide (VCD), a metabolite of 4-vinylcyclohexene (VCH), is synthesized in industries as an intermediate diluent for epoxy resins and other epoxides.

  • GC25626 structure
    GC25626MELK-8a Dihydrochloride
    CAS: 1922153-17-0 (free base)
    Purity: >98%

    MELK-8a Dihydrochloride is a novel inhibitor of maternal embryonic leucine zipper kinase (MELK) with an IC50 of 2 nM.

  • GC25638 structure
    GC25638Miransertib (ARQ 092) HCl
    CAS: 1313883-00-9
    Purity: >98%

    Miransertib (ARQ 092) HCl is an orally bioavailable, selective, and potent allosteric Akt inhibitor with IC 50 values of 2.7nM, 14nM, and 8.1nM for Akt1, Akt2, and Akt3, respectively.

  • GC25648 structure
    GC25648MOTS-c
    CAS: 1627580-64-6
    Purity: >98.00%

    MOTS-c is a mitochondrial-derived polypeptide with metabolic regulatory functions.

  • GC25913 structure
    GC25913Selective PI3Kδ Inhibitor 1 (compound 7n)
    CAS: 2088525-31-7
    Purity: >98%

    Selective PI3Kδ Inhibitor 1 (compound 7n) is an inhibitor of PI3Kδ with an IC50 of 0.9 nM and >1000-fold selectivity against other class I PI3K isoforms [PI3K α/γ/β=3670/1460/21300 nM].

  • GC26044 structure
    GC26044VPS34 inhibitor 1 (Compound 19)
    CAS: 1383716-46-8
    Purity: >98%

    VPS34 inhibitor 1 (Compound 19, PIK-III analogue) is a potent and selective inhibitor of VPS34 with an IC50 of 15 nM.

  • GC26049 structure
    GC26049WAY-119064
    CAS: 1198098-03-1
    Purity: >98%

    WAY-119064 is a potent glycogen synthase kinase-3β (GSK-3β) inhibitor with an IC50 value of 80.5 nM.

  • GC30015 structure
    GC30015TMPA
    CAS: 1258275-73-8
    Purity: >98.50%

    TMPA, a Nur77 antagonist, prevents the binding of Nur77 and LKB1 as well as stimulates LKB1 transport to the cytosol and phosphorylation.